Australia's Bioxyne at two-week high on supply deal with Remidose LATAM

Bioxyne

11/05/2026 05:06

** Shares of Bioxyne BXN.AX rise as much as 8.6% to A$0.076, their highest level since April 22

   ** The pharmaceutical firm executes an expanded supply agreement with Remidose LATAM to supply three Dr Watson cannabis flower stock keeping units to Costa Rica

** Says initial shipment to be made prior to June 30, with invoice value to exceed A$500,000 ($361,450)

** Up 71.4% YTD, including the session's moves

($1 = 1.3833 Australian dollars)

 (Reporting by Anjali Singh in Bengaluru)

 ((anjali.singh2@thomsonreuters.com;))